For instance, a review on the neurobiology of ALCAR, carried out by the National Center for Biotechnology Information (NCBI), stated that ALCAR slows the progression of mental decline and has an effect on mitochondria metabolism thus showing promise as a treatment for neurodegenerative diseases
Moreover, subsequent research should investigate the prospective contributions of these interventions beyond sarcopenia, particularly in the realms of preventing or alleviating age-related vascular aging, metabolic syndrome, and frailty
[DOI] [PubMed] [Google Scholar] 29.Vecchiet L, Di Lisa F, Pieralisi G, Ripari P, Menabo R, Giamberardino MA, Siliprandi N
10.1046/j.1365-2125.2003.01717.x 134 SeibelB